Clincosm LogoSign in Get a demo

invasive ductal breast carcinoma

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +14 more
  • Stereotactic body radiotherapy
  • Lattice Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2023

Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Invasive Ductal Breast Carcinoma, Invasive Ductal Carcinoma, Breast, DCIS Trial in United States (Accelerated Partial Breast

Recruiting
  • Invasive Ductal Breast Carcinoma
  • +5 more
  • Accelerated Partial Breast Irradiation
  • Norwalk, Connecticut
  • +8 more
Oct 4, 2022

Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))

Completed
  • Invasive Ductal Breast Carcinoma
  • Degarelix injection(s)
  • Clamart, France
    Hôpital Antoine Béclère
Sep 26, 2022

Invasive Ductal Breast Carcinoma Trial in Worldwide (Carboplatin, Abraxane, MPDL3280A)

Active, not recruiting
  • Invasive Ductal Breast Carcinoma
  • Innsbruck, Austria
  • +40 more
Jul 26, 2022

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • Birmingham, Alabama
  • +859 more
Jul 19, 2021

Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma, Progesterone Receptor-positive Breast Cancer Trial

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +6 more
  • zoledronic acid
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Apr 28, 2020

Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in Philadelphia

Completed
Has Results
  • Ductal Breast Carcinoma in Situ
  • +6 more
  • Behavioral dietary intervention
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 4, 2019

Predict Neoadjuvant Chemotherapy Response in Breast Cancer

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Radiomic, pathomic, and clinical markers
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jul 12, 2019

Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma With Predominant

Unknown status
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • accelerated partial breast irradiation
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 18, 2017

Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Stage IA Breast Cancer Trial in Chicago (magnetic resonance

Withdrawn
  • Ductal Breast Carcinoma in Situ
  • +3 more
  • magnetic resonance thermal imaging
  • laser interstitial thermal therapy
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Oct 14, 2014

Ductal Breast Carcinoma in Situ, Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in

Withdrawn
  • Ductal Breast Carcinoma in Situ
  • +15 more
  • external beam radiation therapy
  • +2 more
  • Cleveland, Ohio
  • +2 more
Dec 7, 2011